It is therefore likely that the combined effects induced by AFB1, such as the sequence specificity of DNA damage, DNA repair inhibition, the enhancement of mutation susceptibility, and the selective advantage of the mutated codon 249 of the p53, all lead to mutations at this gene location in AFB1-related-HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.